Loading patent…
AssigneeClinical Diagnostic Solutions
InventorsHarold Richardson Crews, James Harrison Carter, II, Ted Sena
Estimating the term…
A novel reagent system for use with automated and semi-automated hematology analyzers including an essentially isotonic blood diluting reagent, a blood cell lysing and hemoglobin conversion reagent, and a second lysing reagent for differentiating white blood cells into classes by size and functional characteristics. The diluent reagent enhances properties for counting and sizing blood specimens, while stabilizing cellular volume and cellular integrity for many hours. The blood cell lysing reagent removes red blood cells and enables subsequent enumeration of white blood cells and simultaneous determination of hemoglobin without use of the toxic cyanide anion. The third lysing reagent and a companion quenching differentiates blood cells into classes by size and functional characteristics, based on d.c. impedance volume, conductivity/opacity and light scatter measurements. The companion quenching reagent adjusts pH and conductivity of the final measurement solution to match the analyzer system requirements. Novel methods for use of the reagents with automated and semi-automated hematology analyzers are also provided.
A multi-purpose isotonic diluent reagent consisting of an aqueous solution of from about 1.5 to about 1.8% w/v of a single alkali metal sulfate salt selected from the class consisting of sodium sulfate, potassium sulfate and the mixture of sodium sulfate and potassium sulfate which dissociates into individual ions for establishing isotonicity, osmolality and conductivity of the reagent, and additives of a buffering agent, a chelating agent, an anesthetic agent, and a germicidal agent, the diluent having a pH of 7.0 to 7.2, and osmolality of 285 to 335 milliosmoles/kg and a conductivity 18 to 20 milliSiemens/cm.
Dependencies are inferred from the claim text.